Nobuyuki Mitsui

Dr. Nobuyuki Mitsui


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Frontiers in Psychiatry
Verified
Journal Article
Open access
NDNguyen Tan Dat
Nguyen Tan Dat
NMNobuyuki Mitsui
Nobuyuki Mitsui
SASatoshi Asakura
Satoshi Asakura
KTKeisuke Takanobu
Keisuke Takanobu
YFYutaka Fujii
Yutaka Fujii
IKIchiro Kusumi
Ichiro Kusumi
Suicide is a serious social issue and is often treated using psychological interventions. The current systematic review and meta-analysis aimed to investigate the effectiveness of self-esteem-related interventions on suicidal behaviors. A systematic literature search for randomized controlled trials (RCTs) including a self-esteem component was conducted on 29 May 2021 and updated on 4 April 2022. In total, 12 studies were included in the systematic review and five studies were included in the meta-analysis. Small effect sizes were found for suicidal ideation at post intervention [g = −0.24, 95% CI (−0.48, 0.00)] and a 3-month follow-up [g = −0.36, 95% CI (−0.62, −0.11)]. However, these results should be interpreted cautiously due to the limited number of included studies and varied sample population. In conclusion, the current review suggests that future intervention studies should incorporate self-esteem enhancement in the treatment of suicidal behaviors, especially for suicidal ideation.Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=250882

1 July 2013 in Comprehensive Psychiatry
Verified
Journal Article
Closed access
NMNobuyuki Mitsui
Nobuyuki Mitsui
SASatoshi Asakura
Satoshi Asakura
TITakeshi Inoue
Takeshi Inoue
YSYusuke Shimizu
Yusuke Shimizu
YFYutaka Fujii
Yutaka Fujii
IKIchiro Kusumi
Ichiro Kusumi

1 November 2013 in Comprehensive Psychiatry
Verified
Journal Article
Closed access
NMNobuyuki Mitsui
Nobuyuki Mitsui
SASatoshi Asakura
Satoshi Asakura
YSYusuke Shimizu
Yusuke Shimizu
YFYutaka Fujii
Yutaka Fujii
YKYuki Kako
Yuki Kako
IKIchiro Kusumi
Ichiro Kusumi

19 July 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NMNobuyuki Mitsui
Nobuyuki Mitsui
SASatoshi Asakura
Satoshi Asakura
KTKeisuke Takanobu
Keisuke Takanobu
SWShinya Watanabe
Shinya Watanabe
KTKuniyoshi Toyoshima
Kuniyoshi Toyoshima
IKIchiro Kusumi
Ichiro Kusumi
Suicide has been a leading cause of death among young adult populations in Japan. The aim of this study was to predict major depressive episodes (MDEs) and suicide-related ideation among university students using the Patient Health Questionnaire-9 (PHQ-9) and the Temperament and Character Inventory (TCI). The subjects were 2194 university students who completed the PHQ-9 and TCI in the 1st year (T1) and the PHQ-9 in the 4th year (T2) of university. Multiple logistic regression analysis was performed to predict MDEs and suicide-related ideation at T2. Moreover, recursive partitioning analyses were conducted to reveal the future risk of MDEs and suicide-related ideation. The multiple logistic regression analyses of MDEs and suicide-related ideation at T2 revealed that depressive episodes, suicide-related ideation, and low self-directedness(SD) scores at T1 were significant predictors. The area under the curve of the model for MDEs was 0.858 and that for suicide-related ideation was 0.741. The recursive partitioning analyses revealed that a PHQ-9 summary score ≥15 at T1 predicted a high risk of MDEs at T2 and that both a PHQ-9 summary score ≥5 and a PHQ-9 #9 score ≥1 predicted a high risk of suicide-related ideation at T2. MDEs, suicide-related ideation, and low SD scores are significant predictors of future MDEs and suicide-related ideation.

1 May 2014 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
NMNobuyuki Mitsui
Nobuyuki Mitsui
SASatoshi Asakura
Satoshi Asakura
YSYusuke Shimizu
Yusuke Shimizu
YFYutaka Fujii
Yutaka Fujii
ATAtsuhito Toyomaki
Atsuhito Toyomaki
IKIchiro Kusumi
Ichiro Kusumi
Background: The suicide risk among young adults is related to multiple factors; therefore, it is difficult to predict and prevent suicidal behavior. Aim: We conducted the present study to reveal the most important factors relating to suicidal ideation in Japanese university students with major depressive episodes (MDEs) of major depressive disorder (MDD). Methods: The subjects were 30 Japanese university students who had MDEs of MDD, and were aged between 18 and 26 years old. They were divided into two groups – without suicide risk group (n=15), and with suicide risk group (n=15) – based on the results of the Mini-International Neuropsychiatric Interview. Additionally, healthy controls were recruited from the same population (n=15). All subjects completed the self-assessment scales including the Beck Depression Inventory 2nd edition (BDI-II), the Beck Hopelessness Scale (BHS), Rosenberg's Self-Esteem Scale (RSES), and SF-36v2TM (The Medical Outcomes Study 36-item short-form health survey version 2), and they were all administered a battery of neuropsychological tests. Results: The RSES score of the suicide risk group was significantly lower than the RSES score of the without suicide risk group, whereas the BDI-II score and the BHS score were not significantly different between the two groups. The mean social functioning score on the SF-36v2 of the with suicide risk group was significantly lower than that of the without suicide risk group. Conclusion: The individual's self-esteem and social functioning may play an important role in suicide risk among young adults with MDEs of MDD.

18 July 2022 in Neuropsychopharmacology Reports
Verified
Journal Article
Open access
NMNobuyuki Mitsui
Nobuyuki Mitsui
YFYutaka Fujii
Yutaka Fujii
SASatoshi Asakura
Satoshi Asakura
HIHissei Imai
Hissei Imai
HYHisashi Yamada
Hisashi Yamada
ESEiji Shimizu
Eiji Shimizu
Aim: This systematic review is aimed to update and reintegrate the pharmacotherapy of social anxiety disorder (SAD), including the Japanese medical database.Methods: We conducted a systematic review and meta‐analysis of pharmacotherapy of SAD according to the Medical Information Distribution Service. We used data from a most recent systematic review, and updated search were conducted using MEDLINE, PubMed, CENTRAL, ICTRP, and ICHUSHI from August 1st, 2017 to January 31st, 2022. The outcome were response rates assessed by Clinical Global Impressions Improvement, efficacy assessed by the Liebowitz Social Anxiety Scale (LSAS), and dropout rates. We performed a random effect of meta‐analysis to obtain the differences in each outcome between active medication and placebo. We used RevMan version 5.3 for analyses.Results: We identified 5 studies through update search and performed meta‐analysis for 33 studies on selective serotonin reuptake inhibitor (SSRI) and 6 studies on serotonin noradrenalin reuptake inhibitor (SNRI). The response rate (RR = 1.62) and the LSAS score reduction (mean difference = −9.65) of SSRI, and the response rate (RR = 1.57) and the LSAS score reduction (mean difference = −11.72) of SNRI were significantly different from placebo. The dropout rates of SSRI or SNRI were not significant. The response rates of SSRIs in both Japanese studies (RR = 1.44) and countries other than Japan (RR = 1.67) were significant. Most findings were based on low quality of evidence.Conclusion: SSRIs are valid option for pharmacotherapy of SAD including Japanese patients. SNRIs are another effective option. However, the results should be interpreted cautiously due to several risk of bias.